Gadobenate dimeglumine-enhanced MR angiography of the abdominal aorta and renal arteries

American Journal of Roentgenology

Volumn 179, Issue 6, 2002, Pages 1573-1582

  Kroencke, Thomas J ^a   Wasser, Martin N ^b   Pattynama, Peter M T ^c   Barentsz, Jelle O ^d   Grabbe, Eckhardt ^e   Marchal, Guy ^f   Knopp, Michael V ^g   Schneider, Günther ^h   Bonomo, Lorenzo ⁱ   Pennell, Dudley J ^j   Del Maschio, Alessandro ^k   Hentrich, Hans Rainer ^l   Daprà, Massimo ^m   Kirchin, Miles A ^m   Spinazzi, Alberto ^m   Taupitz, Matthias ^a   Hamm, Bernd ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^g GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^h SAARLAND UNIVERSITY   (Germany)

ⁱ Ospedale Clinicizzato SS Annunziata   (Italy)

^j ROYAL BROMPTON HOSPITAL   (United Kingdom)

^k SAN RAFFAELE HOSPITAL   (Italy)

^l ALTANA PHARMA AG   (Germany)

^m Bracco Imaging SpA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GADOBENATE DIMEGLUMINE;

ABDOMINAL AORTA; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEART PALPITATION; HEMATURIA; HUMAN; IMAGE QUALITY; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NAUSEA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENAL ARTERY; THREE DIMENSIONAL IMAGING; URTICARIA;

EID: 0036891772     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.179.6.1791573     Document Type: Article

References (26)

1. Prince MR, Yucel EK, Kaufman JA, Harrison DC, Geller SC, Dynamic gadolinium-enhanced three-dimensional abdominal MR arteriography. J Magn Reson Imaging 1993;3:877-881.
2. Prince MR. Gadolinium-enhanced MR aortography. Radiology 1994:191:155-164.
3. Prince MR, Narasimham DL, Stanley JC, et al. Breath-hold gadolinium-enhanced MR angiography of the abdominal aorta and its major branches. Radiology 1995;197:785-792.
4. Shetty AN, Shirkhoda A, Bis KG, Alcantara A. Contrast-enhanced three-dimensional MR angiography in a single breath-hold: A novel technique. AJR 1995;165:1290-1292.
5. de Haën C, Cabrini M, Akhnana L, Ratti D, Calabi L, Gozzini L. Gadobenate dimeglumine 0.5 M solution for injection (MultiHance): Pharmaceutical formulation and physicochemical properties of a new magnetic resonance imaging contrast medium. J Comput Assist Tomogr 1999;23[suppl 1]:S161:-S168.
6. Kouwenhoven M. Contrast-enhanced MR angiography: methods, limitations and possibilities. Acta Radiol 1997;412[suppl]:57-67.
7. Cavagna FM, Maggioni F, Castelli PM, et al. Gadolinium chelates with weak binding to serum proteins: A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol 1997;32:780-796.
8. Knopp MV, Schoenberg SO, Rehm C. et al. Assessment of gadobenate dimeglumine (Gd-BOPTA) for MR angiography: Phase I studies. Invest Radiol 2002 (in press).
9. Criteria Committee of the American Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels, 9th Ed. New York: Little, Brown, 1994.
10. Arlart IP, Gerlach A, Kolb M, Erpenbach S, Wurstlin S. MR angiography using Gd-DTPA in staging of abdominal aortic aneurysm: A correlation with DSA and CT [in German]. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1997;167:257-263.
11. Postma CT, Joosten FB, Rosenbusch G, Thien T. Magnetic resonance angiography has a high reliability in the detection of renal artery stenosis. Am J Hypertens 1997;10:957-963.
12. Bakker J, Beek FJ, Beutler JJ, et al. Renal artery stenosis and accessory renal arteries: Accuracy of detection and visualization with gadolinium-enhanced breathhold MR angiography. Radiology 1998;207:497-504.
13. Hany TF. Leung DA. Pfammatter T, Debatin JF. Contrast-enhanced magnetic resonance angiography of the renal arteries: Original investigation. Invest Radiol 1998;33:653-659.
14. Thornton J, O'Callaghan J, Walshe J, O'Brien E, Varghese JC, Lee MJ. Comparison of digital subtraction angiography with gadolinium-enhanced magnetic resonance angiography in the diagnosis of renal artery stenosis. Eur Radiol 1999;9:930-934.
15. Völk M, Strotzer M, Lenhart M, et al. Time-resolved contrast-enhanced MR angiography of renal artery stenosis: Diagnostic accuracy and interobserver variability. AJR 2000;174:1583-1588.
16. Korst MBJM, Joosten FBM, Postma CT, Jager GJ, Krabbe JK, Barentsz JO. Accuracy of normal-dose contrast-enhanced MR angiography in assessing renal artery stenosis and accessory renal arteries. AJR 2000;174:629-634.
17. Mayo-Smith WW, Saini S, Slater G, Kaufman JA. Sharma P, Hahn PF. MR contrast material for vascular enhancement: Value of superparamagnetic iron oxide. AJR 1996;166:73-77.
18. Anzai Y, Prince MR, Chenevert TL, et al. MR angiography with an ultrasmall superparamagnetic iron oxide blood pool agent. J Magn Reson Imaging 1997;7:209-214.
19. Grist TM, Korosec FR, Peters DC, et al. Steady-state and dynamic MR angiography with MS-325: Initial experience in humans. Radiology 1998;207:539-544.
20. Weishaupt D, Rühm SG, Binkert CA. et al. Equilibrium-phase MR angiography of the aortoiliac and renal arteries using a blood pool contrast agent. AJR 2000;175:189-195.
21. Völk M, Strotzer M, Lenhart M, et al. Renal time-resolved MR angiography: Quantitative comparison of gadobenate dimeglumine and gadopentetate dimeglumine with different doses. Radiology 2001;220:484-488.
22. Carvlin MJ, Arger PH. Kundel HL, et al. Use of Gd-DTPA and fast gradient-echo and spin-echo MR imaging to demonstrate renal function in the rabbit. Radiology 1989;170:705-711.
23. May DA, Pennington DJ. Effect of gadolinium concentration on renal signal intensity: An in vitro study with a saline bag model. Radiology 2000;216:232-236.
24. Hany TF, Schmidt M, Hilfiker PR, Steiner P, Bachmann U, Debatin JF. Optimization of contrast dosage for gadolinium-enhanced 3D MRA of the pulmonary and renal arteries. Magn Reson Imaging 1998;16:901-906.
25. Westenberg JJ, van der Geest RJ, Wasser MN, et al. Vessel diameter measurements in gadolinium contrast-enhanced three-dimensional MRA of peripheral arteries. Magn Resort Imaging 2000;18:13-22.
26. Kirchin MA, Pirovano G, Venetianer C, Spinazzi A. Safety assessment of gadobenate dimeglumine (Multihance): Extended clinical experience from phase I studies to post-marketing surveillance. J Magn Reson Imaging 2001;14:281-294.